纳米甲基D-酸盐 (NMDA) 受体对抗剂及其药理含义:以药物化学为导向的视角概要
Vikas Rana1, Shayantan Ghosh1, Akanksha Bhatt1
1Department of Pharmacy, Graphic Era Hill University, Dehradun, India.
Current medicinal chemistry
|April 19, 2024
概括
N-甲基-D-酸盐 (NMDA) 受体对抗剂对于预防过度激活引起的神经元死亡至关重要. 本综述探讨了NMDA受体结构,来自各种来源的对抗剂,以及通过血脑屏障提高其有效性的策略.
科学领域:
- 神经科学是一个神经科学.
- 药理学 药理学是指药理学的学科.
- 药用化学 医学化学
背景情况:
- N-甲基-D-酸盐 (NMDA) 受体对于突触可塑性,记忆和学习至关重要.
- 过度激活NMDA受体导致刺激毒性和神经元死亡,与神经系统疾病有关.
- 抗NMDA受体对手对于预防刺激毒性和神经元损伤至关重要.
研究的目的:
- 审查NMDA受体子单元的结构和对agonist和antagonist结合的构造变化.
- 探索来自合成,半合成和自然来源的NMDA抗剂,详细说明它们的机制和药理作用.
- 讨论测试NMDA抗体的方法,包括体内和体外模型,以及改善血脑屏障透的药物化学方法.
主要方法:
- 对NMDA受体结构和功能的文献综述.
- 汇编和分析来自不同来源的NMDA抗剂报告.
- 检查结构-活性关系和药物化学策略,用于NMDA抗剂的发展.
- 对评估NMDA抗剂疗效的体外和体外模型的审查.
主要成果:
- 详细描述NMDA受体子单元结构和激素/对抗剂诱导的形状变化.
- 各种NMDA对抗剂的全面概述,包括它们的来源,作用机制和药理意义.
- 讨论NMDA抑制剂的化学间隔和相关的测试模型.
- 制定药物化学策略,以提高NMDA抗剂的有效性,特别是关于血脑屏障的透.
结论:
- 了解NMDA受体结构和对手相互作用是开发神经保护剂的关键.
- 存在各种各样的NMDA对抗剂,提供各种治疗潜力.
- 优化通过血脑屏障传递NMDA对手对于治疗神经系统疾病的临床疗效至关重要.
相关概念视频
01:14Antiepileptic Drugs: Glutamate Antagonists
325
Glutamate is a fundamental neurotransmitter in the central nervous system, playing a vital role in neuronal communication and various cognitive processes. Glutamate stands as the principal excitatory neurotransmitter in the brain. Its presence is crucial for the communication between neurons, underpinning essential processes such as synaptic transmission, neuronal excitability, and plasticity. These functions are vital for higher-order cognitive processes, including learning and memory. The...
325
01:30Ligand-Gated Ion Channel Receptor: Gating Mechanism
2.2K
Ligand-gated ion channels are transmembrane proteins that play a vital role in intercellular communication and functions of the nervous system. They allow the influx of ions across the membrane once the neurotransmitter binds, allowing the subsequent transmission of electrical excitation across the neurons. Other ligand-gated ion channels, like the γ-aminobutyric acid (GABA) receptor, permit anions like chloride into the cells on the binding of the GABA molecule. Their entry into the cell...
2.2K
01:19Ligand-gated Ion Channels
12.4K
Ligand-gated ion channels are transmembrane proteins with a channel for ions to pass through and a binding site for a ligand. The channel opens only when a ligand attaches to the binding site.
Three Subfamilies of Ligand-gated Ion Channels
Ligand-gated ion channels fall into three subfamilies. The 'Cys-loop' includes the nicotinic acetylcholine receptors, γ-aminobutyric acid (GABA), glycine, and 5-hydroxytryptamine receptors. The second one is the 'Pore-loop' channels that...
Three Subfamilies of Ligand-gated Ion Channels
Ligand-gated ion channels fall into three subfamilies. The 'Cys-loop' includes the nicotinic acetylcholine receptors, γ-aminobutyric acid (GABA), glycine, and 5-hydroxytryptamine receptors. The second one is the 'Pore-loop' channels that...
12.4K
01:28Drug-Receptor Interaction: Antagonist
2.9K
An antagonist is a drug that binds strongly to a receptor without activating it. An antagonist prevents other molecules, such as neurotransmitters or hormones, from binding to the receptor and triggering a cellular response. Such interaction effectively hinders the normal physiological processes mediated by the receptor, resulting in various pharmacological effects depending on the specific receptor targeted.
Antagonists can be classified as competitive or noncompetitive based on their...
Antagonists can be classified as competitive or noncompetitive based on their...
2.9K
01:17Nondepolarizing (Competitive) Neuromuscular Blockers: Mechanism of Action
1.8K
Nondepolarizing neuromuscular blockers induce paralysis by competitively blocking nicotinic acetylcholine receptors at the muscle end plate. Examples include pancuronium, mivacurium, vecuronium, and rocuronium. These quaternary ammonium derivatives are administered intravenously, are poorly absorbed, and are excreted via the kidneys.
Competitive antagonists prevent acetylcholine from binding to its receptor, inhibiting membrane depolarization. Without conformational changes or intrinsic...
Competitive antagonists prevent acetylcholine from binding to its receptor, inhibiting membrane depolarization. Without conformational changes or intrinsic...
1.8K
01:29Cholinergic Antagonists: Chemistry and Structure-Activity Relationship
2.2K
Cholinergic antagonists bind to cholinergic receptors and limit the effects of acetylcholine and other cholinergic agonists. Based on the specific cholinergic receptor affinity, these antagonists are classified as muscarinic or nicotinic. Anticholinergics interrupt parasympathetic innervations while sympathetic innervations remain uninterrupted. Muscarinic antagonists are also called 'muscarinic antagonists', 'antimuscarinics', or 'parasympatholytics'. Nicotinic...
2.2K